Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89,474 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intravenous methotrexate at a dose of 1 g/m2 incorporated into RCHOP prevented CNS relapse in high-risk DLBCL patients: A prospective, historic controlled study.
Wang W, Zhang Y, Zhang L, Yang C, Feng J, Cai H, Chen M, Cao X, Zhuang J, Zhu T, Duan M, Zhang W, Li J, Zhou D. Wang W, et al. Among authors: zhang l, zhang w, zhang y. Am J Hematol. 2020 Apr;95(4):E80-E83. doi: 10.1002/ajh.25723. Epub 2020 Jan 22. Am J Hematol. 2020. PMID: 31925808 Free article. No abstract available.
Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China.
Zhang Y, Zhang W, Li J, Duan M, Han B, Zhu T, Zhuang J, Cai H, Cao X, Chen M, Zhou D. Zhang Y, et al. Among authors: zhang w. Ann Hematol. 2019 Jan;98(1):143-150. doi: 10.1007/s00277-018-3488-1. Epub 2018 Sep 12. Ann Hematol. 2019. PMID: 30209556 Clinical Trial.
Combined gemcitabine, cisplatin, dexamethasone, methotrexate, and pegaspargase (GDP-ML) for patients with newly diagnosed extranodal natural killer/T cell lymphoma, nasal type: a single arm, single center, prospective phase 2 study.
Wei C, Cao X, Zhang W, Zhang Y, Wang W, Zhang L, Yang C, Feng J, Cai H, Chen M, Mao Y, Zhou D. Wei C, et al. Among authors: zhang l, zhang w, zhang y. Ann Hematol. 2020 Dec;99(12):2801-2809. doi: 10.1007/s00277-020-04036-z. Epub 2020 May 13. Ann Hematol. 2020. PMID: 32399707 Clinical Trial.
Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China.
Xu XH, Zhang L, Cao XX, Li J, Zhang W, Zhu TN, Cai HC, Chen M, Han X, Yang C, Han B, Zhang Y, Zhuang JL, Zhou DB, Duan MH. Xu XH, et al. Among authors: zhang l, zhang w, zhang y. J Infect Chemother. 2017 Jun;23(6):360-367. doi: 10.1016/j.jiac.2017.02.011. Epub 2017 Mar 22. J Infect Chemother. 2017. PMID: 28341518
89,474 results
You have reached the last available page of results. Please see the User Guide for more information.